RiverVest Venture Management’s Spruce Biosciences SPRB Stock Holding History

RiverVest Venture Management’s Portfolio SPRB Stock Details SPRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.39M	Hold	39,150	–	–	20.39%	2
2024 Q2	$1.52M	Hold	39,150	–	–	22.27%	2
2024 Q1	$2.31M	Hold	39,150	–	–	28.35%	2
2023 Q4	$8.6M	Hold	39,150	–	–	31.72%	2
2023 Q3	$6.64M	Hold	39,150	–	–	16.41%	3
2023 Q2	$6.31M	Hold	39,150	–	–	7%	4
2023 Q1	$6.49M	Buy	39,150 +10,506	+37%	+$1.95M	7.51%	4
2022 Q4	$2.36M	Hold	28,644	–	–	2.75%	5
2022 Q3	$2.94M	Hold	28,644	–	–	3.42%	5
2022 Q2	$3.74M	Hold	28,644	–	–	5.49%	5
2022 Q1	$4.32M	Hold	28,644	–	–	4.43%	6
2021 Q4	$9.58M	Hold	28,644	–	–	6.84%	5
2021 Q3	$12.9M	Hold	28,644	–	–	2.17%	4
2021 Q2	$24.1M	Hold	28,644	–	–	4.71%	3
2021 Q1	$35.7M	Hold	28,644	–	–	5.49%	3
2020 Q4	$52.2M	Buy	+28,644	New	+$47.5M	5.74%	2

Other funds holding SPRB

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RiverVest Venture Management's SPRB Position: Q3 2024 in Review

RiverVest Venture Management held its Spruce Biosciences (SPRB) position steady in Q3 2024 at 39,150 shares worth $1.39M. The position accounts for 20.39% of the portfolio, ranked #2.

RiverVest Venture Management first reported a position in SPRB in Q4 2020 and has held it in 16 quarters since. The position peaked at $52.2M in Q4 2020. 29 funds tracked by Wall St. Rank hold SPRB as of Q3 2024.

RiverVest Venture Management held 39,150 shares of Spruce Biosciences worth $1.39M as of Q3 2024.
RiverVest Venture Management left its Spruce Biosciences share count unchanged in Q3 2024.
Spruce Biosciences made up 20.39% of RiverVest Venture Management's portfolio in Q3 2024, its #2 holding.
RiverVest Venture Management first reported a position in Spruce Biosciences in Q4 2020 and has held it in 16 quarters since.
RiverVest Venture Management's Spruce Biosciences position peaked at $52.2M in Q4 2020.
29 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2024.

Based on RiverVest Venture Management's 13F filing for Q3 2024, filed 30 Oct 2024.